Engraftment of syngeneic and allogeneic endothelial cells, hepatocytes and cholangiocytes into partially hepatectomized rats previously treated with mitomycin C.
BACKGROUND
Pretreatment with retrorsine crosslinks host hepatocyte DNA and prevents proliferation after partial hepatectomy (PH), allowing selective expansion of transplanted progenitors. Shortcomings are length of protocol and carcinogenicity of retrorsine.


METHODS
This report describes a rapid liver repopulation protocol using mitomycin C (MMC) to block proliferation of rat hepatocytes in response to PH. One week post-MMC treatment, dipeptidyl peptidase IV negative host rats were given a PH followed by injection of late gestation, newborn, or adult total liver isolates from dipeptidyl peptidase IV positive rats. For allogeneic transplantation, host rats received injections of anti-CD3 antibody before and after PH.


RESULTS
Host liver staining 2 to 9 weeks posttransplantation revealed well-defined donor hepatocyte colonies with strong canalicular dipeptidyl peptidase IV activity. At the same cell dose, fetal and newborn isolates produced more colonies than adult liver isolates. Hepatocyte colonies also coexpressed marker proteins characteristic of adult hepatocytes and showed polarized localization of plasma membrane proteins. Host livers contained large clusters of sinusoids lined by dipeptidyl peptidase IV positive endothelial cells coexpressing the endothelial cell marker, RECA-1, but lacked the canalicular marker leucine aminopeptidase. Colonies containing donor hepatocytes, endothelial cells, and bile ducts were also observed. Similar levels of engraftment and expansion were achieved with allogeneic liver cell isolates by using anti-CD3 antibody treatment.


CONCLUSIONS
The MMC transplantation model provides a rapid method for engraftment and expansion of hepatocytes, endothelial cells, and cholangiocytes and should be applicable to investigations centering on the role of endothelial cells in liver regeneration and the identification and characterization of putative endothelial, hepatocyte, and cholangiocyte progenitors.
Brilliant
Kate E
KE
Department of Medicine, Division of Hematology and Oncology, Rhode Island Hospital, Providence, RI 02903, USA.
Mills
David R
DR
Callanan
Helen M
HM
Hixson
Douglas C
DC
D000818:Animals; D000831:Animals, Newborn; D001652:Bile Ducts / Q000166:cytology / Q000201:enzymology / Q000637:transplantation*; D002454:Cell Differentiation; D049109:Cell Proliferation / Q000187:drug effects; D018819:Dipeptidyl Peptidase 4 / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D042783:Endothelial Cells / Q000166:cytology / Q000201:enzymology / Q000637:transplantation*; D005260:Female; D006082:Graft Enhancement, Immunologic; D006498:Hepatectomy; D022781:Hepatocytes / Q000166:cytology / Q000187:drug effects / Q000201:enzymology / Q000637:transplantation*; D008115:Liver Regeneration; D016685:Mitomycin / Q000494:pharmacology; D011247:Pregnancy; D011763:Pyrrolizidine Alkaloids / Q000494:pharmacology; D051381:Rats; D011912:Rats, Inbred ACI; D011916:Rats, Inbred F344; D011922:Rats, Mutant Strains; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
D011763:Pyrrolizidine Alkaloids; D016685:Mitomycin; D018819:Dipeptidyl Peptidase 4; C003300:retrorsine
Exp Cell Res. 2004 Oct 15;300(1):134-48
15383321
Kidney Int. 1998 Jun;53(6):1783-91
9607213
Exp Mol Pathol. 2000 Aug;69(1):17-26
10891289
J Histochem Cytochem. 1996 Oct;44(10):1101-8
8813074
Isr J Med Sci. 1981 Jul;17(7):674-7
7287411
Am J Pathol. 2000 Feb;156(2):607-19
10666390
Transplantation. 2003 Sep 27;76(6):988-94
14508367
Physiol Rev. 2003 Apr;83(2):417-32
12663864
Oncogene. 1999 May 27;18(21):3261-76
10359532
Transplantation. 2006 Jul 15;82(1 Suppl):S30-2
16829792
Transplantation. 1997 Aug 27;64(4):650-4
9293881
Clin Microbiol Rev. 1998 Apr;11(2):231-66
9564563
Am J Pathol. 1997 Aug;151(2):353-9
9250149
Science. 2001 Oct 19;294(5542):559-63
11577199
Gastroenterology. 1993 Mar;104(3):840-52
7680017
Biochem J. 1991 Feb 1;273 ( Pt 3):497-502
1705112
Pneumologie. 1994 Mar;48(3):197-201
8197078
Am J Physiol Cell Physiol. 2005 Apr;288(4):C850-62
15561761
Blood. 2000 Feb 1;95(3):952-8
10648408
J Cancer Res Clin Oncol. 1988;114(2):137-41
3127399
Science. 2003 Feb 7;299(5608):890-3
12574630
Transplantation. 2006 Jul 15;82(1 Suppl):S6-8
16829797
Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):123-7
8278351
Transplantation. 2002 Apr 27;73(8):1236-43
11981414
Am J Pathol. 2001 Oct;159(4):1323-34
11583960
Cell Mol Biol Res. 1995;41(1):39-47
7550451
Cancer Chemother Pharmacol. 1989;24(1):50-3
2541938
Drug Metab Rev. 2004 Feb;36(1):1-55
15072438
Int J Exp Pathol. 2005 Dec;86(6):415-30
16309546
Biochem J. 1989 Aug 15;262(1):327-34
2573346
Am J Physiol Gastrointest Liver Physiol. 2000 Oct;279(4):G815-26
11005770
J Hepatol. 1999 Dec;31(6):1069-74
10604581
Lab Invest. 1961 Jul-Aug;10:744-50
13758395
Transplantation. 1999 Aug 27;68(4):563-71
10480417
J Immunol. 2001 Apr 15;166(8):5258-64
11290811
Development. 2006 Nov;133(21):4269-79
17021035
Curr Opin Pharmacol. 2007 Aug;7(4):418-25
17611158
J Toxicol Sci. 1984 Feb;9(1):51-6
6433039
Hepatology. 2006 Feb;43(2):325-34
16440345
Pharmacol Rev. 1970 Dec;22(4):429-83
4921839
Hepatology. 1991 Jan;13(1):47-56
1988344
Chromosoma. 1997 Nov;106(6):348-60
9362543
Exp Mol Pathol. 2000 Jun;68(3):152-69
10816384
Cancer. 1980 Jan 15;45(2):236-44
7351010
Transplantation. 1996 Mar 15;61(5):798-803
8607186
Transplantation. 2006 Jul 15;82(1 Suppl):S25-9
16829790
Cell Transplant. 2005;14(1):41-7
15789661
J Toxicol Environ Health B Crit Rev. 1998 Oct-Dec;1(4):271-346
9776954
Lab Invest. 1992 Apr;66(4):459-66
1583886
Hepatology. 2006 Dec;44(6):1411-20
17133480
Transplantation. 2006 Jul 15;82(1 Suppl):S4-5
16829795
J Toxicol Sci. 1995 Feb;20(1):1-7
7595969
Lancet. 2001 Jan 6;357(9249):33-7
11197359
Cancer Res. 1990 Aug 1;50(15):4755-63
1695125
Am J Clin Oncol. 1997 Jun;20(3):282-4
9167754
N Engl J Med. 1998 Dec 3;339(23):1657-64
9834302